1210490

Ruben D. Kowalyszyn, MD — FEI 3027239040

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Viedma (Argentina)

Additional Details

Clinical Investigator (CI)